Urinary Nerve Growth Factor Levels Are Increased in Patients with Bladder Outlet Obstruction with Overactive Bladder Symptoms and Reduced After Successful Medical Treatment

Urology

Volumn 72, Issue 1, 2008, Pages 104-108

  Liu, Hsin Tzu ^a   Kuo, Hann Chorng ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

5 ALPHA REDUCTASE INHIBITOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; ENZYME INHIBITOR; NERVE GROWTH FACTOR;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE CLASSIFICATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SYMPTOMATOLOGY; URODYNAMICS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CREATININE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; PROSTATIC HYPERPLASIA; URINARY BLADDER NECK OBSTRUCTION; URINARY BLADDER, OVERACTIVE;

EID: 45849142127     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.01.069     Document Type: Article

References (25)

1. Steers W.D., Kolbeck S., Creedon D., et al. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest 88 (1991) 1709-1715
2. Tuttle J.B., Steers W.D., Albo M., et al. Neural input regulates tissue NGF and growth of the adult urinary bladder. J Auton Nerv Syst 49 (1994) 147-158
3. Dupont M.C., Spitsberegen J.M., Kim K.B., et al. Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 166 (2001) 1111-1118
4. Kim J.C., Kim D.B., Seo S.I., et al. Nerve growth factor and vanilloid receptor expression, and detrusor instability, after relieving bladder outlet obstruction in rats. BJU Int 94 (2004) 915-918
5. Lowe E.M., Anand P., Terenghi G., et al. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 79 (1997) 572-577
6. Okragly A.J., Niles A.L., Saban R., et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol 161 (1999) 438-442
7. Murray E., Malley S.E., Qiao L.Y., et al. Cyclophosphamide induced cystitis alters neurotrophin and receptor tyrosine kinase expression in pelvic ganglia and bladder. J Urol 172 (2004) 2434-2439
8. Kim J.C., and Park E.Y. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder syndrome. Int J Urol 12 (2005) 875-880
9. Kim J.C., and Park E.Y. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 175 (2006) 1773-1776
10. Yokoyama T., Kumon H., Nagai A., et al. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder. Neurourol Urodyn (2007) Epub Oct 8
11. Bosch J.L., Hop W.C., Kirkels W.J., et al. Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the community. Urology 46 suppl A (1995) 34-40
12. Kuo H.C. Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms. Urology 70 (2007) 272-276
13. Kuo H.C. Videourodynamic characteristics and lower urinary tract symptoms of female bladder outlet obstruction. Urology 66 (2005) 1005-1009
14. Nixion A., Colman S., Sabounjian L., et al. A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol 174 (2005) 604-607
15. Abrams P., Cardozo L., Fall M., et al. The standardization of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 21 (2002) 167-181
16. Hyman M.J., Groutz A., and Blaivas J.G. Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings. J Urol 166 (2001) 550-552
17. Nitti V.W., Kim Y., and Combs A.J. Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings. J Urol 157 (1997) 600-603
18. Digesu G.A., Khullar V., Cardozo L., et al. Overactive bladder symptoms: do we need urodynamics?. Neurourol Urodyn 22 (2003) 105-108
19. Lommatzsch M.A., Braun A., Mannsfeldt A., et al. Abundant production of brain-derived neurotrophic factor by adult visceral epithelia: implications for paracrine and target-derived neurotrophic function. Am J Pathol 155 (1999) 1183-1193
20. Chung Y.C., Fraser M.O., Yu Y., et al. The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor. J Urol 165 (2001) 975-979
21. Lamb K., Gebhart G.F., and Bielefeldt K. Increased nerve growth factor expression triggers bladder overactivity. J Pain 5 (2004) 150-156
22. Steers W.D., and Tuttle J.B. Mechanisms of diseases: the role of nerve growth factor in the pathophysiology of bladder disorders. Nature Clin Pract Urol 3 (2006) 101-110
23. Abrams P.H. Detrusor instability in bladder outlet obstruction. Neurourol Urodyn 4 (1985) 317-324
24. Birder L.A., Wolf-Johnston A., Griffiths D., et al. Role of urothelial nerve growth factor in human bladder function. Neurourol Urodyn 26 (2007) 405-409
25. Yamaguchi O. Response of bladder smooth muscle cells to obstruction: signal transduction and the role of mechanosensors. Urology 63 suppl 3A (2004) 11-16